PF 44(1) Table of Contents Publish date: November 1, 2017 PROPOSED IRA: Proposed Interim Revision Announcements USP MONOGRAPHS IN-PROCESS REVISION: In-Process Revision GENERAL NOTICES FOR USP-NF General Notices to USP-NF (USP42-NF37) 1. TITLE AND REVISION 2. OFFICIAL STATUS AND LEGAL RECOGNITION 3. CONFORMANCE TO STANDARDS 4. MONOGRAPHS AND GENERAL CHAPTERS 5. MONOGRAPH COMPONENTS 6. TESTING PRACTICES AND PROCEDURES 7. TEST RESULTS 8. TERMS AND DEFINITIONS 9. PRESCRIBING AND DISPENSING 10. PRESERVATION, PACKAGING, STORAGE, AND LABELING GENERAL CHAPTERS <7> LABELING (USP42-NF37) <561> ARTICLES OF BOTANICAL ORIGIN (USP42-NF37) <1057> BIOTECHNOLOGY-DERIVED ARTICLES—TOTAL PROTEIN ASSAY (USP42-NF37) <1160> PHARMACEUTICAL CALCULATIONS IN PHARMACY PRACTICE (USP42-NF37) <1176> PRESCRIPTION BALANCES AND VOLUMETRIC APPARATUS USED IN COMPOUNDING (USP42- NF37) REAGENTS, INDICATORS, AND SOLUTIONS Reagent Specifications Aflatoxin B1 [NEW] (USP42-NF37) Aflatoxin B2 [NEW] (USP42-NF37) Aflatoxin G1 [NEW] (USP42-NF37) Aflatoxin G2 [NEW] (USP42-NF37) Clozapine N-Oxide [NEW] (USP42-NF37) Deuterated Ethanol [NEW] (USP42-NF37) Deuterium Chloride Solution [NEW] (USP42-NF37) Deuterium Oxide (USP42-NF37) Isobutyl Chloroformate [NEW] (USP42-NF37) PF 4x(x) Table of Contents 1 | P a g e Polyethylene Glycol 400 [NEW] (USP42-NF37) Polyethylene Glycol 4000 [NEW] (USP42-NF37) Pyridine, Anhydrous [NEW] (USP42-NF37) Trifluoroacetic Acid Ethyl Ester [NEW] (USP42-NF37) Test Solutions Citric Acid TS [NEW] (USP42-NF37) Sodium Chloride TS [NEW] (USP42-NF37) Volumetric Solutions 0.2 N Alcoholic Potassium Hydroxide VS [NEW] (USP42-NF37) 0.002 M Edetate Disodium VS [NEW] (USP42-NF37) 0.01 M Edetate Disodium VS [NEW] (USP42-NF37) REFERENCE TABLES Container Specifications: Container Specifications [NEW] (USP42-NF37) Description and Solubility Description and Relative Solubility of USP and NF Articles [NEW] (USP42-NF37) Description and Solubility - G USP MONOGRAPHS Albuterol Inhalation Aerosol [NEW] (USP42-NF37) Ampicillin and Sulbactam for Injection (USP42-NF37) Atomoxetine Capsules (USP42-NF37) Bendroflumethiazide (USP42-NF37) Benzonatate (USP42-NF37) Betamethasone (USP42-NF37) Bisacodyl (USP42-NF37) Bumetanide (USP42-NF37) Bumetanide Injection (USP42-NF37) Carbidopa and Levodopa Orally Disintegrating Tablets (USP42-NF37) Cefixime (USP42-NF37) Cefixime Capsules [NEW] (USP42-NF37) Cefixime for Oral Suspension (USP42-NF37) Cefixime Tablets (USP42-NF37) Chromium Cr 51 Edetate Injection (USP42-NF37) Desvenlafaxine Extended-Release Tablets [NEW] (USP42-NF37) Diclofenac Sodium Topical Solution [NEW] (USP42-NF37) Ertapenem Sodium [NEW] (USP42-NF37) Ethosuximide (USP42-NF37) Ethosuximide Capsules (USP42-NF37) Ethosuximide Oral Solution (USP42-NF37) Famciclovir Tablets [NEW] (USP42-NF37) Fentanyl (USP42-NF37) Fentanyl Citrate Compounded Injection [NEW] (USP42-NF37) PF 4x(x) Table of Contents 2 | P a g e Fentanyl Citrate and Bupivacaine Hydrochloride Compounded Injection [NEW] (USP42-NF37) Fentanyl Citrate and Ropivacaine Hydrochloride Compounded Injection [NEW] (USP42-NF37) Heparin Lock Flush Solution (USP42-NF37) Heparin Sodium Injection (USP42-NF37) Hydrochlorothiazide Capsules (USP42-NF37) Hydromorphone Hydrochloride (USP42-NF37) Hypromellose Capsule Shell (USP42-NF37) Inamrinone Injection (USP42-NF37) Indium In 111 Ibritumomab Tiuxetan Injection (USP42-NF37) Indium In 111 Satumomab Pendetide Injection (USP42-NF37) Insulin (USP42-NF37) Iobenguane I 131 Injection (USP42-NF37) Iodohippurate Sodium I 123 Injection (USP42-NF37) Iodohippurate Sodium I 131 Injection (USP42-NF37) Rose Bengal Sodium I 131 Injection (USP42-NF37) Levalbuterol Inhalation Solution (USP42-NF37) Levalbuterol Hydrochloride (USP42-NF37) Lovastatin Tablets (USP42-NF37) Magnesium Hydroxide (USP42-NF37) Metaraminol Bitartrate (USP42-NF37) Mitoxantrone Injection (USP42-NF37) Mitoxantrone Hydrochloride (USP42-NF37) Nicotine Polacrilex (USP42-NF37) Orphenadrine Citrate Injection (USP42-NF37) Orphenadrine Citrate Extended-Release Tablets (USP42-NF37) Oxazepam (USP42-NF37) Phenylephrine Hydrochloride Nasal Solution (USP42-NF37) Phenylephrine Hydrochloride Ophthalmic Solution (USP42-NF37) Chromic Phosphate P 32 Suspension (USP42-NF37) Sodium Phosphate P 32 Solution (USP42-NF37) Pramipexole Dihydrochloride Tablets [NEW] (USP42-NF37) Primidone Tablets (USP42-NF37) Propranolol Hydrochloride Injection (USP42-NF37) Pyridostigmine Bromide (USP42-NF37) Risperidone Orally Disintegrating Tablets (USP42-NF37) Salicylic Acid Gel (USP42-NF37) Sertraline Hydrochloride Tablets (USP42-NF37) Suprofen (USP42-NF37) Suprofen Ophthalmic Solution (USP42-NF37) Technetium Tc 99m Albumin Injection (USP42-NF37) Technetium Tc 99m Albumin Colloid Injection (USP42-NF37) Technetium Tc 99m Apcitide Injection (USP42-NF37) Technetium Tc 99m Arcitumomab Injection (USP42-NF37) Technetium Tc 99m Depreotide Injection (USP42-NF37) Technetium Tc 99m Etidronate Injection (USP42-NF37) Technetium 99mTc Fanolesomab Injection (USP42-NF37) Technetium Tc 99m Gluceptate Injection (USP42-NF37) Technetium Tc 99m Lidofenin Injection (USP42-NF37) PF 4x(x) Table of Contents 3 | P a g e Technetium Tc 99m Nofetumomab Merpentan Injection (USP42-NF37) Terbutaline Sulfate (USP42-NF37) Terbutaline Sulfate Injection (USP42-NF37) Terbutaline Sulfate Tablets (USP42-NF37) Triamcinolone Acetonide Nasal Spray (USP42-NF37) Valproic Acid Oral Solution (USP42-NF37) Xenon Xe 127 (USP42-NF37) Xenon Xe 133 Injection (USP42-NF37) DIETARY SUPPLEMENT MONOGRAPHS Ashwagandha Root (USP42-NF37) Powdered Ashwagandha Root (USP42-NF37) Powdered Ashwagandha Root Extract (USP42-NF37) Bitter Orange Fruit Flavonoids Dry Extract [NEW] (USP42-NF37) Krill Oil Capsules (USP42-NF37) Krill Oil Delayed-Release Capsules (USP42-NF37) Lycopene (USP42-NF37) Lycopene Preparation (USP42-NF37) Tomato Extract Containing Lycopene (USP42-NF37) Tienchi Ginseng Root and Rhizome (USP42-NF37) Tienchi Ginseng Root and Rhizome Powder (USP42-NF37) Tienchi Ginseng Root and Rhizome Powder Capsules (USP42-NF37) Tienchi Ginseng Root and Rhizome Powder Tablets (USP42-NF37) Tienchi Ginseng Root and Rhizome Dry Extract (USP42-NF37) Tienchi Ginseng Root and Rhizome Dry Extract Capsules (USP42-NF37) Tienchi Ginseng Root and Rhizome Dry Extract Tablets (USP42-NF37) NF MONOGRAPHS Butylated Hydroxyanisole (USP42-NF37) STAGE 4 HARMONIZATION: Stage 4 Harmonization GENERAL CHAPTERS <1055> BIOTECHNOLOGY-DERIVED ARTICLES—PEPTIDE MAPPING STIMULI TO THE REVISION PROCESS STIMULI TO THE REVISION PROCESS PF 4x(x) Table of Contents 4 | P a g e PF 4x(x) Table of Contents 5 | P a g e .